标题
Battling Chemoresistance in Cancer: Root Causes and Strategies to Uproot Them
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 17, Pages 9451
出版商
MDPI AG
发表日期
2021-08-31
DOI
10.3390/ijms22179451
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- DNA Repair Pathways in Cancer Therapy and Resistance
- (2021) Lan-ya Li et al. Frontiers in Pharmacology
- Cancer drug resistance induced by EMT: novel therapeutic strategies
- (2021) Javier De Las Rivas et al. ARCHIVES OF TOXICOLOGY
- A New Oxaliplatin Resistance-Related Gene Signature With Strong Predicting Ability in Colon Cancer Identified by Comprehensive Profiling
- (2021) Qiu Lin et al. Frontiers in Oncology
- microRNA-499a promotes the progression and chemoresistance of cervical cancer cells by targeting SOX6
- (2020) Yibing Chen et al. APOPTOSIS
- Cisplatin resistance in gastric cancer cells is involved with GPR30‐mediated epithelial‐mesenchymal transition
- (2020) Xiaofeng Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Oral administration of protein nanoparticles: An emerging route to disease treatment
- (2020) Samira Sadeghi et al. PHARMACOLOGICAL RESEARCH
- Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines
- (2020) Barbara Mora-Lagos et al. PLoS One
- Tumor microenvironment complexity and therapeutic implications at a glance
- (2020) Roghayyeh Baghban et al. Cell Communication and Signaling
- Mechanisms of Multidrug Resistance in Cancer Chemotherapy
- (2020) Karol Bukowski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The anti-tumor activity of pralatrexate (PDX) correlates with the expression of RFC and DHFR mRNA in preclinical models of multiple myeloma
- (2020) Cristina Kinahan et al. Oncotarget
- Fluctuating expression of miR-584 in primary and high-grade gastric cancer
- (2020) Laleh Ebrahimi Ghahnavieh et al. BMC CANCER
- Long non-coding RNA: A recently accentuated molecule in chemoresistance in cancer
- (2020) Yang Peng et al. CANCER AND METASTASIS REVIEWS
- Hippo/MST blocks breast cancer by downregulating WBP2 oncogene expression via miRNA processor Dicer
- (2020) Shen Kiat Lim et al. Cell Death & Disease
- LINC00641/miR-582-5p mediate oxaliplatin resistance by activating autophagy in gastric adenocarcinoma
- (2020) Yunfeng Hu et al. Scientific Reports
- GDF15 Repression Contributes to 5-Fluorouracil Resistance in Human Colon Cancer by Regulating Epithelial-Mesenchymal Transition and Apoptosis
- (2020) Bin Wang et al. Biomed Research International
- Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
- (2020) Samson Mathews Samuel et al. Cancers
- The role and mechanisms of action of microRNAs in cancer drug resistance
- (2019) Wengong Si et al. Clinical Epigenetics
- Sirtuin-mediated deacetylation of hnRNP A1 suppresses glycolysis and growth in hepatocellular carcinoma
- (2019) Hao Yang et al. ONCOGENE
- Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials
- (2019) Richard Gray et al. LANCET
- Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer
- (2019) Nicole M. Kettner et al. CLINICAL CANCER RESEARCH
- Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway
- (2019) Wen-Chien Huang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The roles of glucose metabolic reprogramming in chemo- and radio-resistance
- (2019) Jinguan Lin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer
- (2019) Luigi Ippolito et al. ONCOGENE
- High expression of NFAT2 contributes to carboplatin resistance in lung cancer
- (2019) Xi Liu et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Epithelial-to-mesenchymal transition and drug resistance: transitioning away from death
- (2019) Kyung-A Song et al. Journal of Thoracic Disease
- Role of KEAP1/NFE2L2 mutations in the chemotherapeutic response of non-small cell lung cancer patients
- (2019) Youngtae Jeong et al. CLINICAL CANCER RESEARCH
- A view on drug resistance in cancer
- (2019) Neil Vasan et al. NATURE
- Circulating tumor DNA as an early cancer detection tool
- (2019) Andrea Campos-Carrillo et al. PHARMACOLOGY & THERAPEUTICS
- APC loss affects DNA damage repair causing doxorubicin resistance in breast cancer cells
- (2019) Casey D. Stefanski et al. NEOPLASIA
- Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer
- (2018) Santosh Kumar Singh et al. CANCER LETTERS
- Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment
- (2018) Sarah A. Best et al. Cell Metabolism
- Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization
- (2018) Fei Zhao et al. IMMUNITY
- Noncoding RNA:RNA Regulatory Networks in Cancer
- (2018) Jia Chan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality
- (2018) Richard M. Martin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Rediscovery of NF-κB signaling in nasopharyngeal carcinoma: How genetic defects of NF-κB pathway interplay with EBV in driving oncogenesis?
- (2018) Mei Yi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
- (2018) Jean-Charles Soria et al. NEW ENGLAND JOURNAL OF MEDICINE
- Poldip2 is an oxygen-sensitive protein that controls PDH and αKGDH lipoylation and activation to support metabolic adaptation in hypoxia and cancer
- (2018) Felipe Paredes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NEAT1_2—SFPQ axis mediates cisplatin resistance in liver cancer cells in vitro
- (2018) Yi Ru et al. OncoTargets and Therapy
- Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?
- (2018) Venus Sosa Iglesias et al. Frontiers in Oncology
- Targeting Cancer Stem Cells to Overcome Chemoresistance
- (2018) Toni Nunes et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2018) Kathleen Moore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study
- (2018) Mark J. C. van Treijen et al. Frontiers in Endocrinology
- Sensitization of Drug Resistant Cancer Cells: A Matter of Combination Therapy
- (2018) Meghan Leary et al. Cancers
- The role of exosomes and miRNAs in drug-resistance of cancer cells
- (2017) Duc-Hiep Bach et al. INTERNATIONAL JOURNAL OF CANCER
- Implications of ABCG2 Expression on Irinotecan Treatment of Colorectal Cancer Patients: A Review
- (2017) Dorte Lisbet Nielsen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance
- (2017) Romana-Rea Begicevic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Acquired Resistance with Epigenetic Alterations Under Long-Term Antiangiogenic Therapy for Hepatocellular Carcinoma
- (2017) Yoshiteru Ohata et al. MOLECULAR CANCER THERAPEUTICS
- Strategies and challenges for the next generation of antibody–drug conjugates
- (2017) Alain Beck et al. NATURE REVIEWS DRUG DISCOVERY
- Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer
- (2017) Solange Peters et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular alterations contributing to pancreatic cancer chemoresistance
- (2017) Azam Rajabpour et al. PANCREATOLOGY
- When less is more
- (2017) Jocelyn Kaiser SCIENCE
- A New View of Pathway-Driven Drug Resistance in Tumor Proliferation
- (2017) Ruth Nussinov et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- LncRNA UCA1 in anti-cancer drug resistance
- (2017) Haohao Wang et al. Oncotarget
- The molecular mechanisms of chemoresistance in cancers
- (2017) Hua-Chuan Zheng Oncotarget
- Epithelial-mesenchymal transition: potential regulator of ABC transporters in tumor progression
- (2017) Zong-Sheng Jiang et al. Journal of Cancer
- High Expression of MRE11–RAD50–NBS1 Is Associated with Poor Prognosis and Chemoresistance in Gastric Cancer
- (2016) BOLAG LTAN et al. ANTICANCER RESEARCH
- ABC transporters as mediators of drug resistance and contributors to cancer cell biology
- (2016) Jamie I. Fletcher et al. DRUG RESISTANCE UPDATES
- Cancer chemoresistance; biochemical and molecular aspects: a brief overview
- (2016) Saeed Kachalaki et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Approaches for targeting cancer stem cells drug resistance
- (2016) Roberta Rosa et al. Expert Opinion on Drug Discovery
- Natural Polyphenols in Cancer Chemoresistance
- (2016) Saad A. Hussain et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Downregulated DYRK2 expression is associated with poor prognosis and Oxaliplatin resistance in hepatocellular carcinoma
- (2016) Xiubing Zhang et al. PATHOLOGY RESEARCH AND PRACTICE
- Cancer stem cells and chemoresistance: The smartest survives the raid
- (2016) Jihe Zhao PHARMACOLOGY & THERAPEUTICS
- Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo
- (2016) Jie Meng et al. Scientific Reports
- Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition
- (2016) Dongsheng Huang et al. Scientific Reports
- Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
- (2015) Khalid O Alfarouk et al. Cancer Cell International
- Evidence Suggesting That Discontinuous Dosing of ALK Kinase Inhibitors May Prolong Control of ALK+ Tumors
- (2015) A. D. Amin et al. CANCER RESEARCH
- Metabolic Mechanisms of Drug Resistance in Leukemia
- (2015) Birgit Knoechel et al. Cell Metabolism
- Overcome Cancer Cell Drug Resistance Using Natural Products
- (2015) Pu Wang et al. Evidence-based Complementary and Alternative Medicine
- Epithelial-mesenchymal transition and drug resistance in breast cancer (Review)
- (2015) JING HUANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Benefits and Harms of Breast Cancer Screening
- (2015) Evan R. Myers et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
- (2015) Xiaofeng Zheng et al. NATURE
- Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
- (2015) Kari R. Fischer et al. NATURE
- The emerging role of lncRNAs in cancer
- (2015) Maite Huarte NATURE MEDICINE
- Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance
- (2015) Malin Wickström et al. Nature Communications
- Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel
- (2014) C. Vulsteke et al. BREAST CANCER RESEARCH AND TREATMENT
- The Cancer Genome Atlas Research Network: A Sight to Behold
- (2014) Thomas J. Giordano ENDOCRINE PATHOLOGY
- Relationship between RFC gene expression and intracellular drug concentration in methotrexate-resistant osteosarcoma cells
- (2014) J.J. Wang et al. GENETICS AND MOLECULAR RESEARCH
- FOXM1 mediates resistance to docetaxel in gastric cancerviaup-regulating Stathmin
- (2014) Xiaoxiao Li et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Resistance through repopulation
- (2014) Ian F. Tannock NATURE
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial
- (2013) Noriyuki Katsumata et al. LANCET ONCOLOGY
- Intrinsic and Acquired Drug Resistance in Malignant Tumors
- (2012) Theodor Lippert et al. ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
- Taxane resistance in breast cancer: Mechanisms, predictive biomarkers and circumvention strategies
- (2012) S. Murray et al. CANCER TREATMENT REVIEWS
- Current Status of Methods to Assess Cancer Drug Resistance
- (2012) Theodor H. Lippert et al. International Journal of Medical Sciences
- Cancer and Radiation Therapy: Current Advances and Future Directions
- (2012) Rajamanickam Baskar et al. International Journal of Medical Sciences
- Action of bleomycin is affected by bleomycin hydrolase but not by caveolin-1
- (2012) JIANGUO CHEN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Nanoparticle Delivery of Cancer Drugs
- (2011) Andrew Z. Wang et al. Annual Review of Medicine
- Recent advances in apoptosis, mitochondria and drug resistance in cancer cells
- (2011) Inthrani R. Indran et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Micromarkers: miRNAs in cancer diagnosis and prognosis
- (2010) Manuela Ferracin et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Utility of Incorporating Genetic Variants for the Early Detection of Prostate Cancer
- (2009) R. K. Nam et al. CLINICAL CANCER RESEARCH
- Recent Advances in Cancer Therapy: An Overview
- (2009) A. Urruticoechea et al. CURRENT PHARMACEUTICAL DESIGN
- Label-free detection of DNA mutations by SPR: application to the early detection of inherited breast cancer
- (2008) L. G. Carrascosa et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Resistance mechanisms to cancer chemotherapy
- (2008) Kelly Marie Redmond Frontiers in Bioscience-Landmark
- 5-Fluorouracil: Mechanisms of Resistance and Reversal Strategies
- (2008) Ning Zhang et al. MOLECULES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now